Wednesday, 14 March 2012

Peptide-based therapy of influenza virus infection

A new generation of broad-spectrum anti-influenza peptides has been developed with the scope to treat, as well as prevent, flu and a wider range of clinically relevant viral infections by The University of Edinburgh.

Influenza viruses remain a major cause of global, pandemic-scale morbidity and mortality and the need for novel, effective and safe therapies is acute.  In particular, treatments and prophylactics against the entire spectrum of influenza strains, and which are not subject to drug-resistance, are much-needed.

The fight against influenza has been a long one and it's one that is bound to continue though it's clear that the ongoing research continues to push back the dreaded flu.